SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-013326
Filing Date
2019-11-05
Accepted
2019-11-05 16:12:45
Documents
16
Period of Report
2019-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kportola11519.htm   iXBRL 8-K 45842
2 EX-99.1 ex991.htm EX-99.1 310157
8 GRAPHIC logoa01.jpg GRAPHIC 9882
  Complete submission text file 0001628280-19-013326.txt   524986

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptla-20191105.xsd EX-101.SCH 4663
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptla-20191105_cal.xml EX-101.CAL 699
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptla-20191105_def.xml EX-101.DEF 1549
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptla-20191105_lab.xml EX-101.LAB 26142
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptla-20191105_pre.xml EX-101.PRE 13655
15 EXTRACTED XBRL INSTANCE DOCUMENT a8-kportola11519_htm.xml XML 4295
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35935 | Film No.: 191193430
SIC: 2834 Pharmaceutical Preparations